• Acute fentanyl induces opposing directions of changes in tonic and phasic dopamine release patterns and impairs Pavlovian task performance
  Published on 2026-05-14
  2 months ago
• Prenatal serotonin reuptake inhibitor exposure and maternal depression symptoms are associated with altered fetal brain and placental development
  Published on 2026-05-09
  3 months ago
• Sex-specific role of microglia in Δ9-tetrahydrocannabinol-induced disruption of fear memory reconsolidation
  Published on 2026-05-09
  3 months ago
• PET imaging of FAAH in chronic Cannabis users: longitudinal assessment during short-term abstinence
  Published on 2026-05-09
  3 months ago
• Examining fronto-limbic brain and sleep mechanisms of antidepressant effects in cognitive-behavioral therapy for insomnia
  Published on 2026-05-07
  3 months ago
• Computational phenotyping of effort-based decision-making in type-2 diabetes on and off semaglutide
  Published on 2026-05-06
  3 months ago
• Traumatic stress recruits an excitatory orbitofrontal–amygdala pathway to drive maladaptive aggression
  Published on 2026-05-06
  3 months ago

« Previous 1 … 9 10 11 12 13 … 143 Next »

• Methamphetamine conditioned place preference in adolescent mice: Interaction between sex and strain
  Published on 2026-03-01
  5 months ago
• A phase 2 uncontrolled, open-label study of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine) in patients with treatment-resistant depression
  Published on 2026-02-28
  5 months ago
• Prenatal THC exposure and binge-like alcohol drinking in early adolescence: From sex-specific drinking vulnerability to abnormal endocannabinoid-dopamine nexus in the nucleus accumbens
  Published on 2026-02-28
  5 months ago
• Association of polygenic risk for cannabis use disorder with brain structure among youth with and without bipolar disorder
  Published on 2026-02-27
  5 months ago
• Mapping the acute effects of cannabis on multiple memory domains: A randomized, double-blind, placebo-controlled study
  Published on 2026-02-24
  5 months ago
• Evidence-based consensus guidelines for the pharmacological management of substance dependence: Recommendations from the British Association for Psychopharmacology
  Published on 2026-02-24
  5 months ago
• Health risks associated with non-medical use of ketamine in France: National surveillance insights from the French Addictovigilance Network, 2019–2023
  Published on 2026-02-23
  5 months ago

« Previous 1 … 9 10 11 12 13 … 150 Next »

• Editorial Board
  Published on 2026-02-17
  5 months ago
• Strategies for enhancing methodological rigor and clinical relevance of eating disorders-schizophrenia spectrum disorders risk association studies
  Published on 2026-02-13
  5 months ago
• Personality, not cognition, distinguishes chronic ayahuasca and cannabis users from non-users
  Published on 2026-02-12
  6 months ago
• Updating clozapine prescribing guidelines in Italy: a step forward modernity
  Published on 2026-02-11
  6 months ago
• Predictors of treatment success in patients with substance use disorder (SUD) and co-morbid attention deficit/hyperactivity disorder (ADHD): Results from the International Naturalistic Cohort Study of ADHD and SUD (INCAS)
  Published on 2026-02-07
  6 months ago
• Comment on “All-cause and cause-specific mortality in people with mental disorders: a population-based study on risk evaluation, effect modifiers and excess life-years lost in Hong Kong”
  Published on 2026-01-31
  6 months ago
• Major depression and atherosclerotic disease: Linking shared genetics to pathways in blood, brain, heart, and atherosclerotic plaques
  Published on 2026-01-30
  6 months ago

« Previous 1 … 9 10 11 12 13 … 168 Next »